Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus.

Ludovic TrefondNoël ZahrRaphael LhoteMicheline PhaMiguel HiéMakoto MiyaraMatthias PapoQuentin MoyonPierre HausfaterFrancois ChassetJulien HarocheFleur Cohen-AubartAlexis MathianZahir Amoura

Published in: Annals of the rheumatic diseases (2023)

Keyphrases

systemic lupus erythematosus
type diabetes
glycemic control
metabolic syndrome
adipose tissue
insulin resistance